127 related articles for article (PubMed ID: 23876164)
1. Uveitis risk following oral fluoroquinolone therapy: a nested case-control Study.
Forooghian F; Maberley D; Albiani DA; Kirker AW; Merkur AB; Etminan M
Ocul Immunol Inflamm; 2013 Oct; 21(5):390-3. PubMed ID: 23876164
[TBL] [Abstract][Full Text] [Related]
2. Oral Fluoroquinolones and the Risk of Uveitis.
Sandhu HS; Brucker AJ; Ma L; VanderBeek BL
JAMA Ophthalmol; 2016 Jan; 134(1):38-43. PubMed ID: 26512796
[TBL] [Abstract][Full Text] [Related]
3. Oral fluoroquinolones and the risk of retinal detachment.
Etminan M; Forooghian F; Brophy JM; Bird ST; Maberley D
JAMA; 2012 Apr; 307(13):1414-9. PubMed ID: 22474205
[TBL] [Abstract][Full Text] [Related]
4. Bilateral uveitis associated with fluoroquinolone therapy.
Hinkle DM; Dacey MS; Mandelcorn E; Kalyani P; Mauro J; Bates JH; Soukasian SH; Holland GN; Foster CS; Fraunfelder FT; Davis JL; Fraunfelder FW
Cutan Ocul Toxicol; 2012 Jun; 31(2):111-6. PubMed ID: 21981449
[TBL] [Abstract][Full Text] [Related]
5. Association between oral fluoroquinolones and retinal detachment.
Albini TA; Karakousis PC; Abbey AM; Bartlett JG; Flynn HW
Am J Ophthalmol; 2012 Dec; 154(6):919-921.e1. PubMed ID: 23149367
[No Abstract] [Full Text] [Related]
6. Risk for uveitis with oral moxifloxacin: a comparative safety study.
Eadie B; Etminan M; Mikelberg FS
JAMA Ophthalmol; 2015 Jan; 133(1):81-4. PubMed ID: 25275293
[TBL] [Abstract][Full Text] [Related]
7. The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea.
Novell MJ; Morreale CA
Ann Pharmacother; 2010 May; 44(5):826-31. PubMed ID: 20354161
[TBL] [Abstract][Full Text] [Related]
8. Association between oral fluoroquinolone use and retinal detachment.
Pasternak B; Svanström H; Melbye M; Hviid A
JAMA; 2013 Nov; 310(20):2184-90. PubMed ID: 24281462
[TBL] [Abstract][Full Text] [Related]
9. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population.
Seeger JD; West WA; Fife D; Noel GJ; Johnson LN; Walker AM
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):784-92. PubMed ID: 16456878
[TBL] [Abstract][Full Text] [Related]
10. Oral fluoroquinolones and risk of glaucoma.
Yang L; Etminan M; Mikelberg FS
J Glaucoma; 2014 Sep; 23(7):464-6. PubMed ID: 23632400
[TBL] [Abstract][Full Text] [Related]
11. Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control study.
Sodhi M; Sheldon CA; Carleton B; Etminan M
Neurology; 2017 Aug; 89(8):792-795. PubMed ID: 28754842
[TBL] [Abstract][Full Text] [Related]
12. Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.
Hsu SC; Chang SS; Lee MG; Lee SH; Tsai YW; Lin SC; Chen ST; Weng YC; Porta L; Wu JY; Lee CC
PLoS One; 2017; 12(9):e0183813. PubMed ID: 28873440
[TBL] [Abstract][Full Text] [Related]
13. Outpatient gatifloxacin therapy and dysglycemia in older adults.
Park-Wyllie LY; Juurlink DN; Kopp A; Shah BR; Stukel TA; Stumpo C; Dresser L; Low DE; Mamdani MM
N Engl J Med; 2006 Mar; 354(13):1352-61. PubMed ID: 16510739
[TBL] [Abstract][Full Text] [Related]
14. Diplopia and fluoroquinolones.
Fraunfelder FW; Fraunfelder FT
Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
[TBL] [Abstract][Full Text] [Related]
15. Association Between Oral Fluoroquinolone Use and Retinal Detachment.
Raguideau F; Lemaitre M; Dray-Spira R; Zureik M
JAMA Ophthalmol; 2016 Apr; 134(4):415-21. PubMed ID: 26967005
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors for malignant Mediterranean spotted fever indicates that fluoroquinolone treatment has a deleterious effect.
Botelho-Nevers E; Rovery C; Richet H; Raoult D
J Antimicrob Chemother; 2011 Aug; 66(8):1821-30. PubMed ID: 21642652
[TBL] [Abstract][Full Text] [Related]
17. Risk of bleeding and antibiotic use in patients receiving continuous phenprocoumon therapy. A case-control study nested in a large insurance- and population-based German cohort.
Abbas S; Ihle P; Harder S; Schubert I
Thromb Haemost; 2014 May; 111(5):912-22. PubMed ID: 24429904
[TBL] [Abstract][Full Text] [Related]
18. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study.
Etminan M; Brophy JM; Samii A
Neurology; 2014 Sep; 83(14):1261-3. PubMed ID: 25150290
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.
LaPlante KL; Mersfelder TL; Ward KE; Quilliam BJ
Pharmacotherapy; 2008 Jan; 28(1):82-9. PubMed ID: 18154478
[TBL] [Abstract][Full Text] [Related]
20. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.
Eftekhari K; Ghodasra DH; Haynes K; Chen J; Kempen JH; VanderBeek BL
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):745-52. PubMed ID: 24757075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
